🔗 Permalink

Inventor profile of:

Doris Rau

City:

Munich

Country:

Germany

Published Applications:

Last publication date:

2026-04-30

Top Assignees for applications by Doris Rau

The entities that hold a legal rights for patent applications filed by inventor Rau Doris:

AMGEN RESEARCH (MUNICH) GMBH 23 Munich, Germany
Amgen Inc. 10 Thousand Oaks, CA United States
BOEHRINGER INGELHEIM INTERNATIONAL GMBH 2 Ingelheim am Rhein, Germany
Boehringer Ingellheim iInternational Gmbh 1 Ingelheim am Rhein, Germany
Amegen Research (Munich) GmbH 1 Muncih, Germany

Recent patent applications by Rau Doris

Doris Rau from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-30

US20260116972A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#2 | 2025-11-13

US20250346684A1

Chemistry; metallurgy

BINDING MOLECULES FOR BCMA AND CD3

#3 | 2025-09-11

US20250282869A1

Chemistry; metallurgy

HETEROMULTIMER BINDING DLL3 AND CD3

#4 | 2025-09-11

US20250282863A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR MSLN AND CD3

#5 | 2025-05-22

US20250163179A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#6 | 2025-03-20

US20250092133A1

Chemistry; metallurgy

BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3

#7 | 2025-02-27

US20250064927A1

Human necessities

COMPOSITIONS COMPRISING CROSS-SPECIES-SPECIFIC ANTIBODIES AND USES THEREOF

#8 | 2024-12-05

US20240400673A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR MSLN AND CD3

#9 | 2024-11-21

US20240384006A1

Chemistry; metallurgy

CD20 AND CD22 TARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE DISEASES

#10 | 2024-06-27

US20240209078A1

Chemistry; metallurgy

MULTITARGETING BISPECIFIC ANTIGEN-BINDING MOLECULES OF INCREASED SELECTIVITY

#11 | 2024-01-11

US20240010724A1

Chemistry; metallurgy

Antibody Constructs for CDH19 and CD3

#12 | 2023-12-21

US20230406929A1

Chemistry; metallurgy

POLYPEPTIDE CONSTRUCTS BINDING TO CD3

#13 | 2023-02-09

US20230041876A1

Chemistry; metallurgy

Bispecific antibody constructs for CDH3 and CD3

#14 | 2023-02-09

US20230037742A1

Chemistry; metallurgy

Cross-species-specific PSMAxCD3 bispecific single chain antibody

#15 | 2022-11-10

US20220356268A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#16 | 2022-08-11

US20220251243A1

Chemistry; metallurgy

BINDING MOLECULES FOR BCMA AND CD3

#17 | 2022-03-03

US20220064336A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#18 | 2022-03-03

US20220064308A1

Chemistry; metallurgy

Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3

#19 | 2022-02-10

US20220041736A1

Chemistry; metallurgy

Cross-species-specific single domain bispecific single chain antibody

#20 | 2021-09-02

US20210269550A1

Chemistry; metallurgy

Cross-species-specific PSMAxCD3 bispecific single chain antibody

#21 | 2020-11-19

US20200362039A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#22 | 2020-05-07

US20200140558A1

Chemistry; metallurgy

Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3

#23 | 2020-03-26

US20200095319A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

#24 | 2020-03-05

US20200071405A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR CDH19 AND CD3

#25 | 2019-06-06

US20190169310A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#26 | 2019-03-07

US20190070290A1

Human necessities

Compositions comprising cross-species-specific antibodies and uses thereof

#27 | 2019-01-17

US20190016805A1

Chemistry; metallurgy

Antibody constructs for CDH19 and CD3

#28 | 2018-05-24

US20180142021A1

Chemistry; metallurgy

Bispecific antibody constructs for CDH3 and CD3

#29 | 2017-05-18

US20170137538A1

Chemistry; metallurgy

Pharmaceutical compositions with resistance to soluble CEA

#30 | 2017-02-02

US20170029512A1

Chemistry; metallurgy

Antibody constructs for EGFRVIII and CD3

#31 | 2017-02-02

US20170029502A1

Chemistry; metallurgy

Antibody constructs for MSLN and CD3

#32 | 2016-06-23

US20160176973A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#33 | 2016-06-02

US20160152707A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

#34 | 2015-12-24

US20150368343A1

Chemistry; metallurgy

Antibody constructs for CDH19 and CD3

#35 | 2015-01-22

US20150023967A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#36 | 2014-11-27

US20140348837A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#37 | 2014-10-30

US20140322218A1

Chemistry; metallurgy

Antibody Constructs for CDH19 and CD3

#38 | 2013-06-20

US20130156770A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#39 | 2013-06-20

US20130156769A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#40 | 2013-05-23

US20130129730A1

Chemistry; metallurgy

Cross-species-specific PSMAxCD3 bispecific single chain antibody

#41 | 2012-02-09

US20120034228A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#42 | 2011-12-01

US20110293619A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#43 | 2011-11-10

US20110275787A1

Chemistry; metallurgy

Cross-species-specific single domain bispecific single chain antibody

InventorID:

260844 ⎘